Houston faces a $350 million budget deficit, prompting Mayor John Whitmire to announce a citywide hiring freeze. Impacting all departments except police and fire services, this measure aims to address the financial shortfall and improve organizational efficiency. With almost 5,000 vacant positions, the freeze will allow the city to reassess its personnel needs, cut unnecessary expenses, and enhance efficiency. The decision, part of a broader strategy to stabilize finances, involves city council collaboration and aims for transparency with residents.

The FDA has approved Merilog, a rapid-acting insulin biosimilar to Novolog, marking a new advancement in diabetes treatment. Designed to help manage blood sugar levels effectively, Merilog joins the market as a cost-effective alternative. This approval highlights the FDA’s commitment to expanding treatment options and encouraging pharmaceutical competition. Healthcare providers can now offer patients an additional choice for diabetes management, enhancing flexibility and potentially reducing treatment costs. Merilog’s introduction is a significant step forward in addressing the needs of diabetic patients.